{"version":"1.0","type":"link","title":"Immune checkpoint inhibitors plus paclitaxel-based chemotherapy  oxaliplatin-based therapy as first-line treatment for patients with HER2-negative unresectable or metastatic gastric/gastroesophageal junction cancer: results of a multicenter retrospective study.","author_name":"Fang Y 외","author_url":"https://prs-insight.online/author/Fang%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/128371","thumbnail_width":1200,"thumbnail_height":630}